Nevirapine
Product Images NDC 53104-0166

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Nevirapine (NDC 53104-0166). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Caf42378 E171 46e5 9fd5 C02a9823616e 01

The text seems to be a formula for calculating BSA (Body Surface Area) using the height and weight of an individual.*

FDA Label Image

Caf42378 E171 46e5 9fd5 C02a9823616e 02

FDA Label Image

Caf42378 E171 46e5 9fd5 C02a9823616e 03

Each tablet contains Nevirapine USP. It is a prescription medicine that requires following dosage instructions as per the package. Do not use if the safety seal is broken or missing. Store the tablets between the temperature range of 20°C-25°C. Keep them away from children. The medicine is manufactured in India by CIPLA LTD. The given NDC number is 53104-0166-2.*

FDA Label Image

Caf42378 E171 46e5 9fd5 C02a9823616e 04

This is a description for an anti-retroviral medication called Nevirapine. The medication is available in both tablet and suspension form, with instructions for use and dosage information included in the package. The medication is stored at a temperature between 20°C-25°C, and caution is given to ensure that the bottle is not broken or missing upon purchase. Manufacturer contact information is included.*

FDA Label Image

Caf42378 E171 46e5 9fd5 C02a9823616e 05

This is a description for a medication called Nevirapine USP in tablet form that comes in a package of 1000 tablets for batch overprinting. The tablets contain 200mg of the medication and the usual dosage is mentioned as eviraT. The package insert should be referred to for more information about the medication. A caution is given to not use the tablets if the safety seal under the cap is broken or missing. The tablets should be stored at 20°C-25°C and kept out of reach of children. The manufacturer is CIPLA LTD located in Verna, Goa, India with the product code WL 536.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.